Brigham and Women's Hospital is the second largest teaching hospital of Harvard Medical School and the largest hospital in the Longwood Medical Area in Boston, Massachusetts.

There are 793 beds in Brigham and Women's Hospital Vaccine CRS (BWH VCRS).

During the past decade, Brigham and Women's Hospital Vaccine CRS (BWH VCRS) conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Brigham and Women's Hospital Vaccine CRS (BWH VCRS)" #1 collaborator was "HIV Vaccine Trials Network" with 6 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "HIV Prevention Trials Network" with 2 trials as a collaborator, "AIDS Clinical Trials Group" with 1 trials as a collaborator and "CHAVI" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Brigham and Women's Hospital Vaccine CRS (BWH VCRS)" are "HIV Infections" (25 trials), "COVID-19" (2 trials), "SARS-CoV-2" (2 trials), "HIV Infection" (1 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "Brigham and Women's Hospital Vaccine CRS (BWH VCRS)" in a lesser frequency.

Most popular intervention types in "Brigham and Women's Hospital Vaccine CRS (BWH VCRS)" are "Biological" (25 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "DNA-HIV-PT123 vaccine" (2 trials), "Sample collection" (2 trials), "VRC01" (2 trials) and "VRC07-523LS" (2 trials). Other intervention names were less common.

The vast majority of trials in "Brigham and Women's Hospital Vaccine CRS (BWH VCRS)" are 27 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Brigham and Women's Hospital Vaccine CRS (BWH VCRS)". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Brigham and Women's Hospital Vaccine CRS (BWH VCRS), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Brigham and Women's Hospital Vaccine CRS (BWH VCRS), 22 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".